Insights

Gathering insights about Hansoh Bio…

Similar companies to Hansoh Bio

Hansoh Bio Tech Stack

Hansoh Bio uses 6 technology products and services including Baidu Analytics, CNZZ, ScrollReveal, and more. Explore Hansoh Bio's tech stack below.

Baidu Analytics
Analytics
CNZZ
Analytics
ScrollReveal
Javascript Libraries
jQuery
Javascript Libraries
Swiper
Javascript Libraries
Nginx
Web Servers

Media & News

Hansoh Pharmaceutical Group receives financing of $112M.
Upfront Payment: Hansoh Pharma receives $112 million immediately as part of the agreement.
Dec 19, 2024 | thepharmadata.com
Biotheus Inc. partnered with Hansoh Pharmaceutical Group on Mar 1st '24.
Biotheus announced an expansion of its strategic partnership with Hansoh Pharmaceutical Group in March 2024.
Oct 03, 2024 | www.pharmaceutical-technology.com
GlaxoSmithKline partnered with Hspharm on Oct 1st '23.
In October 2023, Glaxo Smith Kline (GSK) formed an exclusive license agreement with Chinese company Hansoh Pharma to market HS-20089, a B7-H4 targeted ADC undergoing Phase I trials in China.
Nov 14, 2023 | blog.abclonal.com
TiumBio Co., Ltd. partnered with Hspharm on Aug 20th '23.
In August, 2022, TiumBio entered into a licensing agreement with Hansoh Pharma for TU2670 for up to $170M plus tiered royalties upon net sales.
Jul 05, 2023 | www.prnewswire.com
Hansoh Pharmaceutical Group is developing TU2670 in Greater China.
Under the terms of the agreement, Hansoh Pharma obtained exclusive rights to develop and commercialize TU2670 in Greater China.
Jul 05, 2023 | www.prnewswire.com
Hansoh Pharmaceutical Group launches EGFR/cMet bispecific antibodies.
In the area of business, Hansoh Pharmaceutical Group introduced EGFR/cMet bispecific antibodies, which are expected to link up with Almonertinib in a deal valued at up to RMB1.468 billion.
Nov 20, 2022 | www.pharmasources.com
KiOmed Pharma partners with Hspharm.
“KiOmed Pharma is very excited to partner with Hansoh Pharma, one of the largest biopharmaceutical entities in Greater China.
Sep 26, 2022 | www.kiomedpharma.com

Hansoh Bio's Email Address Formats

Hansoh Bio uses at least 1 format(s):

Hansoh Bio Email Formats	Example	Percentage
LastF@hspharm.com	DoeJ@hspharm.com	44%
FLast@hspharm.com	JDoe@hspharm.com	10%
First.Last@hspharm.com	John.Doe@hspharm.com	2%
LastF@hspharm.com	DoeJ@hspharm.com	44%

Frequently Asked Questions

Where is Hansoh Bio's headquarters located?

Hansoh Bio's main headquarters is located at 9900 Medical Center Dr Rockville, Maryland 20850 US. The company has employees across 2 continents, including North AmericaAsia.

What is Hansoh Bio's official website and social media links?

Hansoh Bio's official website is hspharm.com and has social profiles on LinkedIn.

How much revenue does Hansoh Bio generate?

As of April 2025, Hansoh Bio's annual revenue reached $15M.

What is Hansoh Bio's NAICS code?

Hansoh Bio's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Hansoh Bio have currently?

As of April 2025, Hansoh Bio has approximately 103 employees across 2 continents, including North AmericaAsia. Key team members include Chief Business Officer: W. S.Chief Scientific Officer: L. L.Head Of Biotherapeutics: Q. L.. Explore Hansoh Bio's employee directory with LeadIQ.

What industry does Hansoh Bio belong to?

Hansoh Bio operates in the Pharmaceutical Manufacturing industry.

What technology does Hansoh Bio use?

Hansoh Bio's tech stack includes Baidu AnalyticsCNZZScrollRevealjQuerySwiperNginx.

What is Hansoh Bio's email format?

Hansoh Bio's email format typically follows the pattern of . Find more Hansoh Bio email formats with LeadIQ.

When was Hansoh Bio founded?

Hansoh Bio was founded in 2019.

Hansoh Bio

Pharmaceutical ManufacturingMaryland, United States51-200 Employees

Hansoh Bio is the U.S.‐based research & development subsidiary of Hansoh Pharma. Our mission is to discover and develop innovative therapies to help patients combat and conquer serious diseases and disorders worldwide. We are supported by our parent company Hansoh Pharma, which is a leading biopharmaceutical company in Asia. Founded in 1995, Hansoh’s rapidly growing workforce of 10,000+ employees, and our fully integrated R&D, manufacturing and commercial capabilities have propelled us into leadership positions across a broad range of therapeutic areas, including CNS, oncology, infectious diseases, and metabolic disorders.